IL146190A0 - Dermal anesthetic agents - Google Patents

Dermal anesthetic agents

Info

Publication number
IL146190A0
IL146190A0 IL14619000A IL14619000A IL146190A0 IL 146190 A0 IL146190 A0 IL 146190A0 IL 14619000 A IL14619000 A IL 14619000A IL 14619000 A IL14619000 A IL 14619000A IL 146190 A0 IL146190 A0 IL 146190A0
Authority
IL
Israel
Prior art keywords
compounds
anesthetic agents
dermal
aminoindane
dermal anesthetic
Prior art date
Application number
IL14619000A
Other languages
English (en)
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of IL146190A0 publication Critical patent/IL146190A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
IL14619000A 1999-06-10 2000-06-06 Dermal anesthetic agents IL146190A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13835399P 1999-06-10 1999-06-10
US17926700P 2000-01-31 2000-01-31
PCT/US2000/015490 WO2000076510A1 (en) 1999-06-10 2000-06-06 Dermal anesthetic agents

Publications (1)

Publication Number Publication Date
IL146190A0 true IL146190A0 (en) 2002-07-25

Family

ID=26836123

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14619000A IL146190A0 (en) 1999-06-10 2000-06-06 Dermal anesthetic agents
IL146190A IL146190A (en) 1999-06-10 2001-10-25 Dermal anesthetic agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146190A IL146190A (en) 1999-06-10 2001-10-25 Dermal anesthetic agents

Country Status (18)

Country Link
US (1) US6413987B1 (zh)
EP (1) EP1185267B1 (zh)
JP (1) JP2003501469A (zh)
CN (1) CN1355700A (zh)
AT (1) ATE335482T1 (zh)
AU (1) AU777517B2 (zh)
BR (1) BR0011028A (zh)
CA (1) CA2376819C (zh)
CY (1) CY1105721T1 (zh)
DE (1) DE60029954T2 (zh)
DK (1) DK1185267T3 (zh)
ES (1) ES2267546T3 (zh)
IL (2) IL146190A0 (zh)
MX (1) MXPA01012632A (zh)
NO (1) NO323856B1 (zh)
NZ (1) NZ515143A (zh)
PT (1) PT1185267E (zh)
WO (1) WO2000076510A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1321139T3 (da) * 2001-12-21 2007-01-02 Chiesi Farma Spa 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte
AR042139A1 (es) 2002-11-26 2005-06-08 Maruishi Pharma Derivados de isoindolina, composicion farmaceutica que los contiene, y uso
US20060079558A1 (en) * 2004-09-27 2006-04-13 Bridge Pharma. Inc. R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2007038325A2 (en) * 2005-09-23 2007-04-05 Bridge Pharma, Inc. Indanylamines and their use for local anesthesia and chronic pain
US20110218218A1 (en) * 2005-09-23 2011-09-08 Bridge Pharma, Inc. Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
JP5789100B2 (ja) 2008-01-22 2015-10-07 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 抽出溶媒を含む、局部的な麻酔および／または疼痛低減のための揮発性麻酔薬組成物
KR20200125765A (ko) * 2011-02-18 2020-11-04 아사나 바이오사이언시스 엘엘씨 아미노인단 화합물 및 통증 치료에서 그것의 용도
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
DK2771320T3 (en) 2011-10-24 2016-10-03 Endo Pharmaceuticals Inc Cyclohexylamines
US9044482B2 (en) 2012-08-15 2015-06-02 Asana Biosciences, Llc Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
US20170296484A1 (en) 2015-11-23 2017-10-19 Grace Therapeutics Llc Topical Film-Forming Spray
MX2021007213A (es) 2018-12-19 2021-09-23 Grace therapeutics Inc Composicion terapeutica de lidocaina intranasal.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923813A (en) 1969-12-19 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindanes
BE760018A (fr) * 1969-12-19 1971-06-08 Christiaens Sa A Nouveau derives du 2-amino-indane, leur preparation et leur utilisation
AR206505A1 (es) * 1972-09-18 1976-07-30 Christiaens Sa A Procedimiento para obtener nuevos derivados de n-fenil-n-aminoalquil-2-aminoindano
ZA738419B (en) 1972-11-06 1974-09-25 Christiaens Sa A New derivatives of 2-aminoindane,the preparation and use thereof
GB1462036A (en) * 1973-02-05 1977-01-19 Manuf Prod Pharma Aminoindane derivatives
GB1468347A (en) * 1973-03-02 1977-03-23 Christiaens Sa A Aminoindanes

Also Published As

Publication number Publication date
WO2000076510A9 (en) 2002-07-04
DK1185267T3 (da) 2006-12-11
AU5596300A (en) 2001-01-02
NO20016037L (no) 2002-02-11
CY1105721T1 (el) 2010-12-22
BR0011028A (pt) 2002-02-19
EP1185267B1 (en) 2006-08-09
AU777517B2 (en) 2004-10-21
MXPA01012632A (es) 2004-03-19
PT1185267E (pt) 2006-12-29
ATE335482T1 (de) 2006-09-15
JP2003501469A (ja) 2003-01-14
ES2267546T3 (es) 2007-03-16
EP1185267A4 (en) 2003-09-03
US6413987B1 (en) 2002-07-02
CA2376819C (en) 2008-09-02
CN1355700A (zh) 2002-06-26
NO20016037D0 (no) 2001-12-10
NO323856B1 (no) 2007-07-16
DE60029954D1 (de) 2006-09-21
WO2000076510A1 (en) 2000-12-21
CA2376819A1 (en) 2000-12-21
EP1185267A1 (en) 2002-03-13
IL146190A (en) 2008-11-03
NZ515143A (en) 2004-05-28
DE60029954T2 (de) 2007-03-08

Similar Documents

Publication Publication Date Title
IL146190A0 (en) Dermal anesthetic agents
MX9702865A (es) Agentes estrogenicos.
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
HK1068136A1 (en) Muscarinic antagonists
HK1071521A1 (en) Use of a composition comprising cis-clomiphene andtrans-clomiphene in the preparation of a medicament for increasing serum levels of testosterone
TR200101962T2 (tr) Sindirim sistemi bozukluklarını tedavi etmek için 4-(aminometil)-piperidin benzamidler
AU3227700A (en) Skin sanitizing compositions
MXPA02012042A (es) Compuestos efectivos como agonistas de beta-2-adrenorreceptor, y como inhibidores de pde4.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
AU2174697A (en) Stabilizer composition
IL135825A0 (en) Use of mirtazapine for treating sleep apneas
HK1018265A1 (en) Piperazino derivatives as neurokinin antagonists
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
BG105710A (en) 5ht1 antagonists for antidepressant therapy
PL327060A1 (en) Application of 2-ethylhexyl alpha-cyano-beta,beta-diphemylacrylate to improve stability of cosmetic compositions containing p-methylbenzylibene camphor in combination with a derivative of dibenzoyl methane
BR0012751A (pt) Benzofuranos serotonérgicos
MY130184A (en) Dermal anesthetic agents
EP1658847A3 (en) Indane derivatives as dermal anesthetic agents
GB9806409D0 (en) Processes for preparing intermediates
ES2187775T3 (es) Imidazopiridinas.
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
AU2002210537A1 (en) (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
BG104839A (en) Chrystalline form of paroxetine